Ultrasound Nanoconverter Programs Immune Response in Tumor and Lymph Nodes
A dual-targeting ultrasonic nanoconverter, engineered via in situ polymerization to co-deliver a sonosensitizer and a STING agonist, has demonstrated the ability to orchestrate spatiotemporal reactive oxygen species (ROS) regulation. By varying ultrasound power, the system induces immunogenic cell death at the primary tumor site while simultaneously activating immune cells within tumor-draining lymph nodes, offering a coordinated strategy to suppress both local growth and metastatic spread.
Continue reading to unlock the full analysis, deeper implications, and why this study may matter for your field.
Unlock Full Briefing — 50% Off with Coupon: ERWMCWYU
Full version includes the complete summary, study significance, and direct link to the original source.
Stay curious. Stay informed — with Science Briefing.
This is a preview briefing. Upgrade to access the full version.
